Imaging the substantia nigra in Parkinson disease and other Parkinsonian syndromes

YJ Bae, JM Kim, CH Sohn, JH Choi, BS Choi, YS Song… - Radiology, 2021 - pubs.rsna.org
Parkinson disease is characterized by dopaminergic cell loss in the substantia nigra of the
midbrain. There are various imaging markers for Parkinson disease. Recent advances in …

[HTML][HTML] Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's …

Z Cheng, N He, P Huang, Y Li, R Tang, SK Sethi… - NeuroImage: Clinical, 2020 - Elsevier
Parkinson's disease (PD) is a clinically heterogeneous chronic progressive neuro-
degenerative disease with loss of dopaminergic neurons in the nigrosome 1 (N1) territory of …

Nigrosome imaging and neuromelanin sensitive MRI in diagnostic evaluation of parkinsonism

N Pavese, YF Tai - Movement disorders clinical practice, 2018 - Wiley Online Library
Background Recent developments in magnetic resonance imaging (MRI) techniques have
offered new research opportunities to visualize in vivo substantia nigra pathology in …

Comparative study of MRI biomarkers in the substantia nigra to discriminate idiopathic Parkinson disease

N Pyatigorskaya, B Magnin, M Mongin… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Several new MR imaging techniques have shown
promising results in patients with Parkinson disease; however, the comparative diagnostic …

[HTML][HTML] Imaging iron and neuromelanin simultaneously using a single 3D gradient echo magnetization transfer sequence: Combining neuromelanin, iron and the …

N He, K Ghassaban, P Huang, M Jokar, Y Wang… - Neuroimage, 2021 - Elsevier
Diagnosing early stage Parkinson's disease (PD) is still a clinical challenge. Previous
studies using iron, neuromelanin (NM) or the Nigrosome-1 (N1) sign in the substantia nigra …

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI

AI Blazejewska, ST Schwarz, A Pitiot, MC Stephenson… - Neurology, 2013 - AAN Enterprises
Objective: This study assessed whether high-resolution 7 T MRI allowed direct in vivo
visualization of nigrosomes, substructures of the substantia nigra pars compacta (SNpc) …

Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

JM Kim, HJ Jeong, YJ Bae, SY Park, E Kim… - Parkinsonism & related …, 2016 - Elsevier
Abstract Background Seven Tesla (7T) MRI can visualize anatomical alterations occurring in
a hyperintense structure of the substantia nigra in Parkinson's disease (PD). Objective We …

The 'swallow tail'appearance of the healthy nigrosome–a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T

ST Schwarz, M Afzal, PS Morgan, N Bajaj… - PloS one, 2014 - journals.plos.org
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease
(PD). An ideal imaging marker would directly mirror the loss of substantia nigra …

Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging

L Minati, M Grisoli, F Carella… - American journal …, 2007 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Visualizing with MR imaging and obtaining quantitative
indexes of degeneration of the substantia nigra in Parkinson disease have been long …

Diffusion tensor imaging of the substantia nigra in P arkinson's disease revisited

J Langley, DE Huddleston, M Merritt… - Human Brain …, 2016 - Wiley Online Library
Objective To analyze diffusion tensor imaging (DTI) data in the substantia nigra (SN) using a
more consistent region of interest (ROI) defined by neuromelanin‐sensitive MRI in order to …